Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Monday, September 28

3:05 PM - 3:10 PM ET

1048 - Randomized Phase II Trial of Stereotactic Body (SBRT) vs. Conventional Fractionation (CF) Radiotherapy Boost for High-Risk Prostate Cancer: Biochemical Control Outcomes of the PBS Trial
Speaker: Ben-Zvi, Libby - McMaster University, Hamilton, ON
3:05 PM - 3:10 PM ET

1054 - Ten-Year Outcomes of Elective Upper-Neck vs. Whole-Neck Irradiation for the Uninvolved Neck in Nasopharyngeal Carcinoma Patients with N0-1 or Unilateral N3 Disease and High Pretreatment Plasma Epstein-Barr Virus DNA Load
Speaker: Tang, Linglong, MD, PhD - Sun Yat-Sen University Cancer Center, Guangzhou, Guangdong
3:05 PM - 3:10 PM ET

1060 - A Dynamic Priority-Aware Diffusion Model for Clinically-Driven Dose Prediction in Radiotherapy
Speaker: Yan, Xianrui - Cancer Hospital of Shandong First Medical University, jinan
3:05 PM - 3:10 PM ET

1072 - Patient prior Personalization Enables Robust CTV Auto-Contouring for Online Adaptive Radiotherapy in Cervical Cancer
Speaker: Wang, Guangyu, MD - Peking Union Medical College Hospital, Beijing, Beijing
3:10 PM - 3:15 PM ET

1043 - The Influence of Cancer Primary Site on Outcomes after Preoperative Radiosurgery for Resected Brain Metastases: A XXX International Multicenter Cohort Study
Speaker: Prabhu, Roshan, MD, MS - Atrium Health Levine Cancer, CHARLOTTE, NC
3:10 PM - 3:15 PM ET

1050 - Five-Year Outcomes from a Prospective Trial of MR-Guided SBRT with Focal DIL Boost for Intermediate-Risk Prostate Cancer
Speaker: Goglia, Alexander, MD, PhD - Memorial Sloan Kettering Cancer Center, New York, NY
3:10 PM - 3:15 PM ET

1055 - A Multicenter, Randomized Controlled Phase III Trial of TPF Induction Chemotherapy vs. PF Adjuvant Chemotherapy Combined with Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma: Long-Term Follow-up Analysis
Speaker: Jin, Feng, BS - Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou
3:10 PM - 3:15 PM ET

1061 - Adaptive Radiotherapy in Hypersensitive and High Locoregional Risk Breast Cancer: Preliminary Results of the SAHARA04 Phase II Trial
Speaker: Prunaretty, Jessica - Institut du Cancer de Montpellier, Montpellier
3:10 PM - 3:15 PM ET

1073 - Eliminating Uncertainties in Post-Treatment Breast Cosmesis Evaluation using Vision-Language Artificial Intelligence
Speaker: Park, Sangjoon, MD, PhD - Yonsei University College of Medicine, Seoul, Seoul
3:10 PM - 3:20 PM ET

211 - The Prognostic Role of Circulating Tumor DNA In Vulvovaginal Cancers Undergoing Radiotherapy
Speaker: Gui, Bin, MD, MS - Northwell Health, Lake Success, NY
3:10 PM - 3:20 PM ET

216 - Overcoming Myeloid-Driven Resistance of High-Grade Gliomas to CAR T Cell Therapy: Mechanistic Determinants and Therapeutic Targeting
Speaker: Gholamin, Sharareh, MD, PhD - City of Hope Comprehensive Cancer Center, Duarte, CA
3:10 PM - 3:20 PM ET

222 - Outcomes from Phase 2 Trial of Preoperative Image Guided Intensity Modulated Photon Radiation Therapy (IMRT) with Simultaneously Integrated Boost (SIB) to the High-Risk Margin for Retroperitoneal Sarcomas (RPS)
Speaker: Liu, Kevin, MD, DPhil - Brigham and Womens Hospital, Boston, MA